Two Sigma Securities’s ResMed RMD Stock Holding History

Two Sigma Securities’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,600	Closed	-$635K	–	2933
2024 Q3	$635K	Sell	2,600 -2,700	-51%	-$603K	0.01%	1141
2024 Q2	$1.01M	Buy	5,300 +4,200	+382%	+$852K	0.01%	1065
2024 Q1	$218K	Buy	+1,100	New	+$202K	﹤0.01%	2267
2023 Q4	–	Sell	-8,500	Closed	-$1.26M	–	3494
2023 Q3	$1.26M	Buy	+8,500	New	+$1.54M	0.01%	902
2023 Q2	–	Sell	-1,600	Closed	-$350K	–	3257
2023 Q1	$350K	Buy	+1,600	New	+$347K	0.01%	1547
2020 Q4	–	Sell	-4,300	Closed	-$737K	–	1902
2020 Q3	$737K	Buy	4,300 +2,800	+187%	+$517K	0.02%	450
2020 Q2	$288K	Buy	+1,500	New	+$245K	0.01%	924
2020 Q1	–	Sell	-1,900	Closed	-$294K	–	2141
2019 Q4	$294K	Buy	+1,900	New	+$274K	﹤0.01%	1804
2019 Q1	–	Sell	-5,300	Closed	-$604K	–	2341
2018 Q4	$604K	Sell	5,300 -6,500	-55%	-$696K	0.01%	895
2018 Q3	$1.36M	Buy	11,800 +2,000	+20%	+$219K	0.01%	898
2018 Q2	$1.01M	Buy	9,800 +6,300	+180%	+$637K	0.01%	1320
2018 Q1	$345K	Buy	+3,500	New	+$331K	﹤0.01%	1912

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Two Sigma Securities's RMD Position: Q2 2025 in Review

Two Sigma Securities sold out of ResMed (RMD) in Q2 2025, closing a stake of 1,372 shares — an estimated $307K sold.

Two Sigma Securities first reported a position in RMD in Q2 2018 and held it in 15 quarters. The position peaked at $703K in Q4 2022. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

Two Sigma Securities reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
Two Sigma Securities sold 1,372 ResMed shares in Q2 2025, an estimated $307K.
Two Sigma Securities first reported a position in ResMed in Q2 2018 and held it in 15 quarters.
Two Sigma Securities's ResMed position peaked at $703K in Q4 2022.
919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.